BGLC

BioNexus Gene Lab (BGLC)

BioNexus Gene Lab Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BGLC

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/03	00 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/11/16	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/11/15	07 : 20	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/11/09	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/10/16	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/10/11	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/09/26	00 : 31	GlobeNewswire Inc.	BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/09/26	00 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/09/14	01 : 05	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/09/13	02 : 23	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/09/12	00 : 05	GlobeNewswire Inc.	BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/08/28	23 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/08/28	00 : 35	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/08/27	01 : 15	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/08/27	01 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 47	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 45	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04 : 45	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/05/10	01 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/04/19	03 : 52	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/27	06 : 05	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/23	21 : 55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/11/03	23 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/09/08	00 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	00 : 30	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/21	02 : 29	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation